Low Dose Naltrexone for Refractory Cancer Pain

Dr. Caleb Knisley from University of South Carolina discusses a study at MDACC on the use of low dose naltrexone for refractory cancer pain. Malik A, Ye A, Chung M. Low Dose Naltrexone for Refractory Cancer Pain: Case Series of Initial Safety and Effectiveness. J Pain Symptom Manage. 2025;70(6):e492-e497. doi:10.1016/j.jpainsymman.2025.08.015 https://pubmed.ncbi.nlm.nih.gov/40849024/

December 2025

Related

You May Also Like

Related lectures

Behavioral Economics

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

September 15, 2026

Preparing for Dementia

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

August 28, 2026

Palliative Care at the End of the Hall

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

August 14, 2026